Becton Dickinson & Co (BDX)
227.39
-2.15
(-0.94%)
USD |
NYSE |
Mar 10, 16:00
228.67
+1.28
(+0.56%)
After-Hours: 20:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 65.29B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -2.17% |
Valuation | |
PE Ratio | 37.77 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 3.202 |
Price to Book Value | 2.591 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | 1.04 |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.7442 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 29.62% |
Profile
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business. |
URL | https://www.bd.com |
Investor Relations URL | https://investors.bd.com/ |
HQ State/Province | New Jersey |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Next Earnings Release | May. 01, 2025 |
Last Earnings Release | Feb. 06, 2025 |
Next Ex-Dividend Date | Mar. 10, 2025 |
Last Ex-Dividend Date | Mar. 10, 2025 |
Ratings
Profile
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business. |
URL | https://www.bd.com |
Investor Relations URL | https://investors.bd.com/ |
HQ State/Province | New Jersey |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Next Earnings Release | May. 01, 2025 |
Last Earnings Release | Feb. 06, 2025 |
Next Ex-Dividend Date | Mar. 10, 2025 |
Last Ex-Dividend Date | Mar. 10, 2025 |